Lymphangioleiomyomatosis

Novartis Pharmaceuticals Corporation

Company2 trialsPhase 3142 people

University of Cincinnati

3 trialsPhase 3174 people

Brigham and Women's Hospital

2 trialsPhase 226 people

National Heart, Lung, and Blood Institute

1 trialPhase 233 people

Children's Hospital Medical Center, Cincinnati

1 trialPhase 225 people

Cardiff University

1 trialPhase 214 people

University of Pennsylvania

1 trialPhase 1/210 people

M.D. Anderson Cancer Center

1 trialPhase 1154 people